Exclusive

Publication

Byline

NSE to build Rs 380 crore facility for cancer treatment at Tata Memorial Centre

India, Oct. 6 -- Country's largest equity bourse NSE on Sunday announced that it will spend '380 crore to build a facility to help in cancer treatment at Tata Memorial Hospital. The 11-storey NSE mul... Read More


Sugar mills gained from ethanol: Amit Shah

India, Oct. 6 -- Ethanol blending has transformed the balance sheets of sugar mills and India's sugar cooperatives sector has benefitted immensely after Narendra Modi became the Prime Minister, Union ... Read More


Clinical Trial: Prospective study on the safety and efficacy of cryobiopsy through a cuffed long tracheal tube (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059295) titled 'Prospective study on the safety and efficacy of cryobiopsy through a cuffed ... Read More


Clinical Trial: Safety evaluation of long-term intake of the test foods containing plant extract B (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059069) titled 'Safety evaluation of long-term intake of the test foods containing plant ext... Read More


Clinical Trial: Middle Cerebral artery flow velocity changes during pneumoperitoneum for laproscopic surgeries- The feasibility of Transcranial colour coded duplex ultrasonography (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000051384) titled 'Middle Cerebral artery flow velocity changes during pneumoperitoneum for la... Read More


Clinical Trial: Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function: a randomized, single-blind trial (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059262) titled 'Efficacy of 12-week continuous application lipids derived from animal at two... Read More


Clinical Trial: A biomarker study associated with a randomized, prospective phase II trial comparing the efficacy and safety of mFOLFOX6 plus cetuximab (q2w) versus mFOLFOX6 plus bevacizumab as first-line treatment for unresectable right-sided colon cancer with RAS/BRAF wild-type (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059294) titled 'A biomarker study associated with a randomized, prospective phase II trial c... Read More


Clinical Trial: A Study of Hard Gummy Candy Chewing Training in Young Children (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059278) titled 'A Study of Hard Gummy Candy Chewing Training in Young Children' on Oct. 6. ... Read More


Clinical Trial: Evaluation of the Effects of Aroma on Autonomic Nervous Activity and Ophthalmic Parameters in Patients with Glaucoma (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059154) titled 'Evaluation of the Effects of Aroma on Autonomic Nervous Activity and Ophthal... Read More


Clinical Trial: Radiological Features of Visceral Pleural Invasion (VPI) in Primary Lung Cancer on Preoperative Chest CT: A Retrospective Observational Study (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059277) titled 'Study on Chest CT Findings Predictive of Visceral Pleural Invasion (VPI) in ... Read More